Sinovac Biotech, Ltd
SVA
SVA was delisted on the 22nd of February, 2019.
24 hedge funds and large institutions have $74.7M invested in Sinovac Biotech, Ltd in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
3% less capital invested
Capital invested by funds: $76.8M → $74.7M (-$2.08M)
4% less funds holding
Funds holding: 25 → 24 (-1)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RQS
Ramsey Quantitative Systems
Louisville,
Kentucky
|
-$150K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$23.2K |
| 3 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
-$594 |
| 4 |
FGAM
Financial Gravity Asset Management
Lakeway,
Texas
|
-$11 |
SVA Hedge Fund Activity: Q2 2019 in Review
24 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Sinovac Biotech, Ltd (SVA) for Q2 2019, worth a combined $74.7M — down 2.7% from $76.8M a quarter earlier.
Fund positioning in SVA was balanced in Q2 2019: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 3 trimmed.
The largest seller was Ramsey Quantitative Systems, exiting entirely with an estimated $150K sold.
- 24 institutional investors held Sinovac Biotech, Ltd (SVA) as of Q2 2019, down from 25 in Q1 2019.
- Funds reported $74.7M of Sinovac Biotech, Ltd stock for Q2 2019, down 2.7% quarter-over-quarter.
- 1 fund opened new Sinovac Biotech, Ltd positions in Q2 2019 and 1 closed out, a net change of 0 holders.
- The largest Sinovac Biotech, Ltd seller in Q2 2019 was Ramsey Quantitative Systems, an estimated $150K sold.
Based on aggregated 13F filings for Q2 2019.